Diagnosis

Renal failure

Acute

  • Injury:  Cr ↑ of 2x baseline, GFR ↓ of 50%, or urine output <0.5mL/kg/h for 12 h

  • Failure: Cr ↑ of 3x baseline, GFR ↓ of 75 %, Cr ≥4.0, or urine output <0.5mL/kg/h

Chronic [oqc]

  • Stage 1: Kidney damage with normal or increased GFR (> 90 mL/min/1.73 m2)

    • Albuminuria (> 30 mg/24 hr or albumin:creatinine ratio > 30 mg/g [> 3 mg/mmol])

    • Urine sediment abnormalities

    • Electrolyte and other abnormalities due to tubular disorders

    • Histologic abnormalities

    • Structural abnormalities detected by imaging

    • History of kidney transplantation

  • Stage 2: Mild reduction in GFR (60-89)

  • Stage 3a: Moderate reduction in GFR (45-59)

  • Stage 3b: Moderate reduction in GFR (30-44)

  • Stage 4: Severe reduction in GFR (15-29)

  • Stage 5: Kidney failure (GFR < 15 or dialysis)

Also known as: Acute kidney injury, Acute renal failure, Kidney failure

Etiology

Cause of acute renal failure [eoz][6yt]

Cause of chronic renal failure [4be]

Pathophysiology [eoz][4be]

  1. Kidney functions: EPO/vitamin D production, acid-base homeostasis, fluid/electrolyte regulation, and waste-product elimination

  2. Glomerular filtration is based on pressure difference between the glomerulus and Bowman's space

  3. Acute renal failure: Ischemia/toxins --> cellular insult --> cell death --> renal failure

    • Prerenal: Reduction in renal blood flow (under the direct control of the combined resistances of afferent and efferent vascular pathways)

    • Intrarenal: Intratubular obstruction (myoglobin, uric acid crystals in tumor lysis syndrome, immunoglobulin light chains), immune-mediated injury of the vasculature, immune complex deposition leading to glomerular and tubular damage

    • Postrenal: urinary reflux --> decreased renal perfusion, tubular atrophy, and interstitial inflammation

  4. Chronic renal failure: sustained insults --> progressive nephropathy --> kidney fibrosis in the glomeruli (glomerulosclerosis), tubules and interstitium (tubulointerstitial fibrosis), and vessels (vascular sclerosis)

    • Prerenal: Decreased renal perfusion (chronic heart failure or cirrhosis)

    • Intrinsic renal:

      • Vascular: nephrosclerosis (chronic damage to blood vessels, glomeruli, and the tubulointerstitium), renal artery stenosis, fibromuscular dysplasia

      • Nephritic disease: abnormal urine microscopy due to post-infectious glomerulonephritis, infective endocarditis, IgA nephropathy, lupus nephritis, Goodpasture syndrome, and vasculitis

      • Nephrotic disease: proteinuria >3.5 g/24 h due to minimal change disease, focal segmental glomerulosclerosis, membranous glomerulonephritis, diabetic nephropathy, and amyloidosis

      • Tubular and interstitial disease: Polycystic kidney disease, nephrocalcinosis, sarcoidosis, Sjögren syndrome, and reflux nephropathy

    • Postrenal: prostatic disease, nephrolithiasis, abdominal/pelvic tumor, ureteropelvic or ureterovesical junction stenosis, retroperitoneal fibrosis or neurogenic bladder

  5. Renal failure --> accumulation of water, sodium, and other metabolic products

  6. Uremia (urine in the blood):

    • Fluid/electrolyte imbalance

    • Hormonal abnormalties

    • Accumulation of nitrogenous waste products (urea)

Complications [eoz][4be]

Epidemiology

Incidence per 100.000 [ksr]

Epidemiology chart for Incidence

Approach

Acute vs Chronic renal failure

Treatment

Acute renal failure: [6yt]

  1. Treat life threatening features:

    • Hypotension/shock: IV fluid

    • Hypervolemia/pulmonary edema: IV furosemide during the oliguric phase of ATN

    • Hyperkalemia: Dietary restriction, Insulin, IV dextrose, beta-agonists, potassium-binding resins, calcium gluconate, dialysis

    • Acidosis: citrate or bicarbonate

    • Hyperphosphatemia: dietary ingestion or using phosphate binders

  2. Treat cause of acute renal failure:

    • Prerenal/dehydration/hypovolumia: IV fluids, bowel obstruction, blood transfusion

    • Renal: Treat the underlying condition (avoid drugs, immunosuppression)

    • Postrenal: Relief of obstruction (double-J stent, lithotripsy, pyelostomi, surgery)

  3. Renal Replacement Therapy (intermittent or continuous):

    • Severe hyperkalemia, unresponsive to medical therapy

    • Fluid overload with pulmonary edema

    • Uraemia (blood urea >30–50 mmol/l)

    • Complications of severe uraemia: encephalopathy, pericarditis, neuromyopathy

    • Severe acidosis (pH <7.1)

    • Drug overdose with a dialysable toxin

Chronic renal failure: [oqc]

  1. Delaying the progression of CKD: Treatment of the underlying condition

    • Diabetes

    • Hypertension

    • Nephrotoxins: radiocontrast, NSAIDs, aminoglycosides, AR-blocker/ACE-inhibitor

    • Autoimmune kidney disease

  2. Treating the pathologic manifestations of CKD:

    • Diet: Protein/salt/phosphate/potassium/volume restriction

    • Anemia: erythropoiesis-stimulating agents and iron

    • Hyperphosphatemia: phosphate binders and dietary phosphate restriction

    • Hypocalcemia: calcium supplements

    • Hyperparathyroidism: calcitriol or vitamin D analogues

    • Volume overload: fluid restriction, loop diuretics or ultrafiltration

    • Metabolic acidosis: oral alkali supplementation

    • Uremia --> renal replacement therapy (hemodialysis/peritoneal dialysis)

      • Severe metabolic acidosis

      • Hyperkalemia/hyponatremia/hypercalcemia/hypocalcemia/hyperphosphatemia

      • Pericarditis or pleuritis

      • Encephalopathy

      • Intractable volume overload

      • Hypertension not responsive to antihypertensive medications

      • Failure to thrive and malnutrition

      • Peripheral neuropathy

      • Intractable gastrointestinal symptoms

      • In asymptomatic patients: GFR of 5-9 mL/min/1.73 m²

  3. Kidney transplantation

Differential diagnoses

Alport syndrome, Anemia, Benign prostatic hyperplasia, Diabetes mellitus, Essential hypertension, Gastrointestinal hemorrhage, Glomerulonephritis, Heart failure, Hyperchloremic acidosis, Hyperkalemia, Hypermagnesemia, Hyperparathyroidism, Hyperphosphatemia, Hypocalcemia, Hypothyroidism, Hypovolemia, Malignant hypertension, Multiple myeloma, Pericarditis, Prostate cancer, Renal artery stenosis, Subdural hematoma, Urinary retention, Urinary tract infection, Urolithiasis


References

[1] http://emedicine.medscape.com/article/238798 (2014-01-02); [Medscape]

[2] Goyal A, Daneshpajouhnejad P, Hashmi MF, et al. Acute Kidney Injury. [Updated 2023 Nov 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441896/

[3] Fry AC, Farrington K. Management of acute renal failure. Postgrad Med J. 2006 Feb;82(964):106-16.

[4] Vaidya SR, Aeddula NR. Chronic Kidney Disease. [Updated 2024 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535404/

[5] Akrawi DS, Li X, Sundquist J, Sundquist K, Zöller B. Familial risks of kidney failure in Sweden: a nationwide family study. PLoS One. 2014 Nov 25;9(11):e113353.

[6] Mehta, R.L., Kellum, J.A., Shah, S.V. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11, R31 (2007).

Scroll to top